BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Catalyst Pharmaceuticals To Present At 14th Annual BIO Investor Forum

  October 19, 2015

   · 

  4 min read
• Business

  Luc Therapeutics Announces License And Collaboration Agreement To Accelerate Development Of Its Program For The Treatment Of Depression

  October 19, 2015

   · 

  3 min read
• Business

  Vittamed Nabs $10 Million for Commercialization of Non-Invasive ICP System

  October 19, 2015

   · 

  3 min read
• Business

  18-Year Old Launches Bioplastics Startup Firm

  October 19, 2015

   · 

  1 min read
• Drug Development

  OXiGENE Announces Interim Phase II Data For Lead Clinical Candidate CA4P (Fosbretabulin) In Neuroendocrine Tumors

  October 19, 2015

   · 

  4 min read
• Business

  Allergan Successfully Completes AqueSys Acquisition, Adding XEN45 Minimally Invasive Implantable Shunt for Glaucoma

  October 19, 2015

   · 

  5 min read
• Drug Development

  Janssen Research & Development Release:Phase 3 Data Show STELARA Induced Clinical Response And Remission In The Treatment Of Patients With Moderate To Severe Crohn’s Disease

  October 19, 2015

   · 

  13 min read
• Business

  Cempra To Report Third Quarter 2015 Financial Results

  October 19, 2015

   · 

  2 min read
• Drug Development

  Celator Pharmaceuticals, Inc. Announces Positive Recommendation From Data And Safety Monitoring Board For Phase 3 Study Of CPX-351 (VYXEOS)

  October 19, 2015

   · 

  5 min read
• Drug Development

  Sprout Release: Addyi (Flibanserin), First-Ever Medical Treatment For Acquired, Generalized HSDD In Premenopausal Women, Now Available

  October 19, 2015

   · 

  9 min read